Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study tests tools to spot repeat blood clots

NCT ID NCT02297373

Knowledge-focused Sponsor: Ottawa Hospital Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 744 people who had a blood clot before and were suspected of having another one. Researchers tested three different checklists (called clinical decision rules) to see how well they could tell if a new clot was really there. The goal was to help doctors avoid missing dangerous clots or giving unnecessary blood thinners.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

744 people

The number who actually took part.

Started

Nov 2014

Finished

Jan 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Outpatients presenting with suspected acute recurrent venous thromboembolism (VTE).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Outpatients with clinically suspected acute recurrent DVT or PE regardless of whether the previous event was a DVT or PE * Age ≥18 years old * Willing and able to give informed consent Exclusion Criteria: * Life expectancy less than 3 months * Suspicion of upper extremity thrombosis or thrombosis at an unusual site (e.g. cerebral or abdominal venous thrombosis) * Previous VTE was distal DVT or subsegmental PE * Suspected recurrent VTE is asymptomatic * Previously enrolled in this study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deep vein thrombosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pulmonary embolism Thromboembolism venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deep vein thrombosis Pulmonary embolism Recurrent thromboembolic disease Thromboembolic disease recurrent Venous thromboembolism

Contacts and locations

Locations

  • Geneva University Hospital

    Geneva, Switzerland

  • Hamilton Health Sciences Centre

    Hamilton, Ontario, L8L 2X2, Canada

  • Hopital Montfort

    Ottawa, Ontario, K1K 0T2, Canada

  • Humber River Hospital

    Toronto, Ontario, M3M 0B2, Canada

  • Lawson Health Research Institute

    London, Ontario, N6G 4A5, Canada

  • Leiden University Medical Centre

    Leiden, Netherlands

  • Nova Scotia Health Authority

    Halifax, Nova Scotia, B3H 1V7, Canada

  • Sir Mortimer B. Davis Jewish General Hospital

    Montreal, Quebec, H3T 1E2, Canada

  • The Ottawa Hospital

    Ottawa, Ontario, K1H 8L6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.